RNASET2 ,GPR174 , and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves’ disease-Reference-Cited by-同舟云学术

RNASET2 ,GPR174 , and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves’ disease

Published:2017-05-31 Issue:2 Volume:32 Page:e22258
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Zhang Qing¹,Liu Shaozheng¹,Guan Yanxing¹,Chen Qingjie¹,Zhang Qing¹,Min Xiang²^ORCID

Affiliation:

1. Department of Nuclear Medicine; the First Affiliated Hospital of Nanchang University; Nanchang Jiangxi China

2. Department of Otolaryngology & Head and Neck Surgery; the First Affiliated Hospital of Nanchang University; Nanchang Jiangxi China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference31 articles.

1. Management of Graves disease: a review;Burch;JAMA,2015

2. Robust evidence for five new Graves’ disease risk loci from a staged genome-wide association analysis;Zhao;Hum Mol Genet,2013

3. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves’ disease in a Chinese Han population;Xue;PLoS ONE,2013

4. RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population;Chen;BMC Med Genet,2015

5. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves’ disease;He;Exp Clin Endocrinol Diabetes,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical manifestations and early effectiveness of methimazole in patients with graves’ hyperthyroidism-related severe hepatic dysfunction;Scandinavian Journal of Gastroenterology;2023-08-07

2. Research Progress of Liver Function Impairment Associated with Hyperthyroidism;Advances in Clinical Medicine;2023

3. A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease;Endocrine;2022-09-30

4. Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves’ Disease;Frontiers in Cell and Developmental Biology;2022-01-04

5. Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine;Journal of Medicinal Chemistry;2021-07-07